Pimavanserin for Insomnia in Veterans With PTSD
Pimavanserin for Insomnia in Veterans With Post-traumatic Stress Disorder
VA Office of Research and Development
60 participants
Dec 28, 2023
INTERVENTIONAL
Conditions
Summary
This is a preliminary randomized, double-blind, placebo-controlled trial comparing pimavanserin 34mg at bedtime vs. placebo for the treatment of insomnia associated with post-traumatic stress disorder.
Eligibility
Plain Language Summary
Simplified for easier understanding
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
pimavanserin 34mg PO at bedtime
The placebo is a pill that looks like a study medication but has no medication in it
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05441280